Tuesday Feb 7 | Seeking Alpha
ViroPharma (VPHM) -4.3% premarket after the FDA rejects its proposal ...
ViroPharma -4.3% premarket after the FDA rejects its proposal to expand manufacturing of Cinryze, its treatment for angioedema, a type of swelling similar to hives.
Related Topix: Biotech, ViroPharma, Medicine, Healthcare Industry, Health
Is an Israeli Strike on Iran "Inevitable"?
Topix Staff Story Ahmadinejad spent the weekend trolling Israel by talking up Iran's "very big ...
Also on Topix
1 hr ago | Fox News
New Jersey's state Senate passes gay marriage bill, Chris...
1 hr ago | CBS
China cops beat Tibet monk as he burns
1 hr ago | USA Today
Fresh violence in Syria as U.N. warns of civil war
4 hrs ago | USA Today
Israel blames Iran for attacks on its diplomats
4 hrs ago | Fox News
UN Security Council visits Haiti to evaluate earthquake r...
8 hrs ago | WaPo
Roger Federer says he did not blame Swiss teammate Wawrin...
8 hrs ago | WaPo
Are Tiger Woods, Phil Mickelson returning to form after P...
8 hrs ago | WaPo
The Grammys recap: Whitney Houston, Adele, Chris Brown an...
9 hrs ago | WaPo
Congress looks for ways around Supreme Court
13 hrs ago | NY Times
ArtsBeat: Steve Jobs Monologue Downloadable, Free
Recent activity of our hottest topics
Deland, FL
Long Branch, NJ
Whitney Houston
Newton County, GA
Douglas, MA
Venice, FL
Forsyth County, GA
Banning, CA
Hayward, CA
The Bachelor
Bowie, MD
Bahrain
|
Casco, WI |
Explore More Topix |
About Topix |
Local Classifieds & Listings Reach Local customers. Post a classified listing for your business. Promote job, auto, rental, and local event listings. Join the Topix Community
|
Updated: Tue Feb 07, 2012 07:24 am
Copyright ©2012 Topix LLC